<DOC>
	<DOCNO>NCT01764581</DOCNO>
	<brief_summary>ImmuKnow detect cell-mediated immunity solid-organ transplant recipient undergo immunosuppressive therapy . Increasing ImmuKnow value indicate decrease immunosuppression decrease ImmuKnow value suggest increase immunosuppression . The test measure amount ATP produce CD4+ lymphocytes biomarker lymphocyte activation . This study use ImmuKnow assay proactively adjust immunosuppressive therapy adult liver transplant recipient reduce risk adverse event</brief_summary>
	<brief_title>Randomized Controlled Trial ImmuKnow Liver Transplantation</brief_title>
	<detailed_description>We perform randomize prospective interventional trial Interventional group immunosuppression modify accord ImmuKnow value . Immunosuppression decrease 25 % ImmuKnow value less 130 ng/mL ATP . Similarly , immunosuppression increase 25 % ImmuKnow value great 450 ng/mL ATP . Immunosuppression Control group manage Standard Care institution . ImmuKnow perform liver transplant , surgery clinic visit approximate schedule : day 1 ; weekly , week 1-4 ; week 6 ; week 8 ; monthly , month 3-6 ; month 9 12 . ImmuKnow test repeat within 7 day suspected/confirmed rejection infection within 1 week resolution .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>consecutive adult liver transplant recipient center ; patient enter study ; provide consent . available followup ; consent remove .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>immune monitoring</keyword>
	<keyword>immune cell function ImmuKnow</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>immunosuppression management</keyword>
	<keyword>infection</keyword>
	<keyword>rejection</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>Cylex</keyword>
</DOC>